table of content
1 Introduction to Research & Analysis Reports
1.1 Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunotherapy Overall Market Size
2.1 Global Immunotherapy Market Size: 2022 VS 2031
2.2 Global Immunotherapy Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunotherapy Players in Global Market
3.2 Top Global Immunotherapy Companies Ranked by Revenue
3.3 Global Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunotherapy Market Size Markets, 2022 & 2031
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Vaccines
4.1.4 Checkpoint Inhibitors
4.1.5 Non-Specific Immunotherapy
4.2 By Type - Global Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Immunotherapy Revenue, 2019-2024
4.2.2 By Type - Global Immunotherapy Revenue, 2024-2031
4.2.3 By Type - Global Immunotherapy Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunotherapy Market Size, 2022 & 2031
5.1.2 Oncology
5.1.3 Inflammation
5.1.4 Central Nervous System
5.1.5 Others
5.2 By Application - Global Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Immunotherapy Revenue, 2019-2024
5.2.2 By Application - Global Immunotherapy Revenue, 2024-2031
5.2.3 By Application - Global Immunotherapy Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Immunotherapy Market Size, 2022 & 2031
6.2 By Region - Global Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Immunotherapy Revenue, 2019-2024
6.2.2 By Region - Global Immunotherapy Revenue, 2024-2031
6.2.3 By Region - Global Immunotherapy Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Immunotherapy Revenue, 2019-2031
6.3.2 US Immunotherapy Market Size, 2019-2031
6.3.3 Canada Immunotherapy Market Size, 2019-2031
6.3.4 Mexico Immunotherapy Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Immunotherapy Revenue, 2019-2031
6.4.2 Germany Immunotherapy Market Size, 2019-2031
6.4.3 France Immunotherapy Market Size, 2019-2031
6.4.4 U.K. Immunotherapy Market Size, 2019-2031
6.4.5 Italy Immunotherapy Market Size, 2019-2031
6.4.6 Russia Immunotherapy Market Size, 2019-2031
6.4.7 Nordic Countries Immunotherapy Market Size, 2019-2031
6.4.8 Benelux Immunotherapy Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Immunotherapy Revenue, 2019-2031
6.5.2 China Immunotherapy Market Size, 2019-2031
6.5.3 Japan Immunotherapy Market Size, 2019-2031
6.5.4 South Korea Immunotherapy Market Size, 2019-2031
6.5.5 Southeast Asia Immunotherapy Market Size, 2019-2031
6.5.6 India Immunotherapy Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Immunotherapy Revenue, 2019-2031
6.6.2 Brazil Immunotherapy Market Size, 2019-2031
6.6.3 Argentina Immunotherapy Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunotherapy Revenue, 2019-2031
6.7.2 Turkey Immunotherapy Market Size, 2019-2031
6.7.3 Israel Immunotherapy Market Size, 2019-2031
6.7.4 Saudi Arabia Immunotherapy Market Size, 2019-2031
6.7.5 UAE Immunotherapy Market Size, 2019-2031
7 Immunotherapy Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Immunotherapy Major Product Offerings
7.1.4 Abbvie Immunotherapy Revenue in Global Market (2019-2024)
7.1.5 Abbvie Key News & Latest Developments
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Company Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Immunotherapy Major Product Offerings
7.2.4 Amgen, Inc. Immunotherapy Revenue in Global Market (2019-2024)
7.2.5 Amgen, Inc. Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Immunotherapy Major Product Offerings
7.3.4 Biogen Immunotherapy Revenue in Global Market (2019-2024)
7.3.5 Biogen Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Immunotherapy Revenue in Global Market (2019-2024)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Immunotherapy Major Product Offerings
7.5.4 Celgene Immunotherapy Revenue in Global Market (2019-2024)
7.5.5 Celgene Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Immunotherapy Major Product Offerings
7.6.4 Johnson & Johnson Immunotherapy Revenue in Global Market (2019-2024)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Immunotherapy Major Product Offerings
7.7.4 Merck Immunotherapy Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Immunotherapy Major Product Offerings
7.8.4 Novartis Immunotherapy Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Immunotherapy Major Product Offerings
7.9.4 Pfizer Immunotherapy Revenue in Global Market (2019-2024)
7.9.5 Pfizer Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Immunotherapy Major Product Offerings
7.10.4 Roche Immunotherapy Revenue in Global Market (2019-2024)
7.10.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
